The global blood ketone meter market size is estimated to reach USD 727.8 million by 2030, registering a CAGR of 6.96% from 2025 to 2030, according to a new report by Grand View Research, Inc. Reimbursement scenario and favorable health insurance are significant factors that are anticipated to surge the demand for blood ketone meters. Technological advancements in Type 1 Diabetes care lead to the increasing preference for automated devices among individuals that aid in reducing disease burden.
Diabetes prevalence is increasing worldwide, due to which the number of hospital admissions with patients suffering from complications, including diabetic ketoacidosis (DKA), is also rising. DKA is a severe and life-threatening complication of diabetes. This disease is more common among people with type 1 diabetes and affects around 30 million people across the U.S. Lifestyle changes, rapid urbanization, increased life expectancy, and dietary changes are the major causes of diabetes.
The rise in the geriatric and obese population across the globe is expected to boost the growth of the market. As per the WHO, by 2050, the world’s population aged 60 years and above is likely to reach 2 billion by 2050. Similarly, as per the American Diabetes Association, one-third of U.S. adults aged 65 and above had diabetes in 2017. Thus, a rise in the number of adults with diabetes is anticipated to boost the demand for blood ketone meters during the forecast period.
An increasing number of hospital admissions owing to the rising cases of DKA in developing as well as developed nations are estimated to foster the market growth. According to a Diabetes Care Study, DKA causes approximately 200,000 hospitalizations each year in the U.S. Rising hospital admissions eventually lead to an increase in healthcare costs, thereby fueling the market growth.
Request a free sample copy or view report summary: Blood Ketone Meter Market Report
By product type, the blood glucose and ketone monitoring segment held the largest share in 2024, due to the increasing launch of blood glucose and ketone meters.
Based on application, the veterinary segment is expected to witness considerable growth during the forecast period, due to the increasing application of blood ketone meters among animals.
The hospital end-use segment captured the largest share in 2024, due to the increasing number of hospitalizations every year.
North America held the largest market share in 2024, due to the rising healthcare expenditure and increase in the healthcare spending.
The presence of local and international players and the increasing prevalence of type 1 and type 2 diabetes has led to the surging demand for blood ketone meters in North America.
Grand View Research has segmented the global blood ketone meter market on the basis of product type, application, end-use, and region:
Blood Ketone Meter Product Outlook (Revenue, USD Million, 2018 - 2030)
Blood Ketone Monitoring
Blood Glucose and Ketone Monitoring
Consumables
Blood Ketone Meter Application Outlook (Revenue, USD Million, 2018 - 2030)
Human
Veterinary
Blood Ketone Meter End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Centers
Homecare Settings
Other End Use
Blood Ketone Meter Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players in the Blood Ketone Meter Market
Abbott
Apex Biotechnology Corp.
TaiDoc Technology Corporation
EKF Diagnostics Holdings plc.
Nova Biomedical
Keto-Mojo
ForaCare, Inc.
Nipro
i-SENS, Inc
"The quality of research they have done for us has been excellent..."